Search Results
Results found for "Norton Cheng"
- Targeting Intracellular Allosteric Sites in GPCRs
modulators (NAMs), that fully or partially dampen the receptor's functional response to the ligand (Wold, Chen or more of the following pharmacological characteristics: 1) affinity modulation where the resulting change substantial doses of allosteric modulators with a diminished risk of target-related toxicity (Wold, Chen
- Illuminating C5aR Biology: The Role of Fluorescent Ligands in GPCR Research
.; Chung, K. Y.; Fan, H.; Wei, Z.; Zhang, C.
- Overview of adhesion GPCRs self-activation
structural perspective, the -4 position of αH5 was key for the selectivity of G-protein coupling, since the change ., Zhu, X., Wang, N., Xu, Z., Xia, R., Liang, J., Duan, Y., Yin, H., Xiong, Y., Zhang, A., Guo, C., Chen
- Feeder or trigger – CCR2 as a scavenger and regulator of cell migration
2000), becoming incapable of promoting cell migration, a phenomenon which is likely to be mediated by changes
- Glyco-sulfo hotspots in the chemokine receptor system
extracellular loops and transmembrane domains of the receptor (CRS2), which will trigger conformational changes
- An overview of the compartmentalized GPCR Signaling: Relevance and Implications
the lipid composition of intracellular membranes may influence GPCR dynamics and signaling outcomes, changing Pharmaceuticals (Basel, Switzerland), 14(5), 439. https://doi.org/10.3390/ph14050439 Chen, K.
- Artificial intelligence – faster, smarter, cheaper GPCR drug discovery
, such as ligand binding sites (orthosteric, allosteric), activation mechanisms, and conformational changes
- Unlocking the Therapeutic Potential of Previously Undruggable GPCRs
These interactions induce local conformational changes which are amplified and transmitted to the intracellular the fully integrated PROcisionXᵀᴹ discovery platform Structure-based validation of Orion’s approach Zheng
